We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$18.8B
AUM Growth
+$1.08B
Cap. Flow
+$375M
Cap. Flow %
1.99%
Top 10 Hldgs %
32.3%
Holding
1,384
New
65
Increased
662
Reduced
357
Closed
63

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$243M
2
PLD icon
Prologis
PLD
+$106M
3
DLR icon
Digital Realty Trust
DLR
+$97.4M
4
KIM icon
Kimco Realty
KIM
+$96.3M
5
SNOW icon
Snowflake
SNOW
+$88.7M

Top Sells

Rank Stock Value
1
O icon
Realty Income
O
+$225M
2
INVH icon
Invitation Homes
INVH
+$153M
3
EQIX icon
Equinix
EQIX
+$91.3M
4
SPG icon
Simon Property Group
SPG
+$91.1M
5
AMT icon
American Tower
AMT
+$91M

Sector Composition

Rank Sector Weight
1 Real Estate 42.05%
2 Technology 19.13%
3 Communication Services 6.55%
4 Consumer Discretionary 6.17%
5 Financials 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COGT icon
1226
Cogent Biosciences
COGT
$6.91B
$2K ﹤0.01%
281
CSTL icon
1227
Castle Biosciences
CSTL
$741M
$2K ﹤0.01%
86
CVAC
1228
DELISTED
CureVac
CVAC
$2K ﹤0.01%
697
EOLS icon
1229
Evolus
EOLS
$407M
$2K ﹤0.01%
162
HROW icon
1230
Harrow
HROW
$1.4B
$2K ﹤0.01%
110
ITOS
1231
DELISTED
iTeos Therapeutics
ITOS
$2K ﹤0.01%
121
KALV
1232
DELISTED
KalVista Pharmaceuticals
KALV
$2K ﹤0.01%
154
LXRX icon
1233
Lexicon Pharmaceuticals
LXRX
$991M
$2K ﹤0.01%
1,369
+935
+215% +$1.68K
MLYS icon
1234
Mineralys Therapeutics
MLYS
$2.4B
$2K ﹤0.01%
152
OABI icon
1235
OmniAb
OABI
$294M
$2K ﹤0.01%
475
OLMA icon
1236
Olema Pharmaceuticals
OLMA
$1.05B
$2K ﹤0.01%
224
ORIC icon
1237
Oric Pharmaceuticals
ORIC
$1.24B
$2K ﹤0.01%
249
PHAT icon
1238
Phathom Pharmaceuticals
PHAT
$953M
$2K ﹤0.01%
167
PLRX icon
1239
Pliant Therapeutics
PLRX
$66.9M
$2K ﹤0.01%
196
PRME icon
1240
Prime Medicine
PRME
$544M
$2K ﹤0.01%
398
REPL icon
1241
Replimune Group
REPL
$724M
$2K ﹤0.01%
200
RGNX icon
1242
Regenxbio
RGNX
$622M
$2K ﹤0.01%
146
SIGA icon
1243
SIGA Technologies
SIGA
$222M
$2K ﹤0.01%
270
SLRN
1244
DELISTED
ACELYRIN
SLRN
$2K ﹤0.01%
398
SRRK icon
1245
Scholar Rock
SRRK
$5.86B
$2K ﹤0.01%
208
SVRA icon
1246
Savara
SVRA
$1.11B
$2K ﹤0.01%
553
THRD
1247
DELISTED
Third Harmonic Bio
THRD
$2K ﹤0.01%
149
TSHA icon
1248
Taysha Gene Therapies
TSHA
$1.59B
$2K ﹤0.01%
691
TVTX icon
1249
Travere Therapeutics
TVTX
$5.27B
$2K ﹤0.01%
258
VYGR icon
1250
Voyager Therapeutics
VYGR
$187M
$2K ﹤0.01%
201

Similar funds

Daiwa Securities Group's Q2 2024 Portfolio in Review

As of Q2 2024, Daiwa Securities Group held 1,384 positions worth $18.8B, up 6.1% from $17.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group's Q2 2024 filing shows 65 new, 662 increased, 357 reduced and 63 closed positions. Its largest new stake was NextEra Energy 7.299% Corporate Units: 500,000 shares worth $24.6M. The largest sale was Realty Income, an estimated $225M.

By sector, the portfolio is most concentrated in Real Estate at 42% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 500,000 shares worth $24.6M.
  • Daiwa Securities Group added most to Crown Castle in Q2 2024, an estimated $243M increase.
  • Daiwa Securities Group's biggest Q2 2024 reduction was Realty Income, cutting an estimated $225M.
  • Daiwa Securities Group fully exited Apartment Income REIT Corp. in Q2 2024, selling an estimated $88.4M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $18.8B portfolio in Q2 2024.
  • Daiwa Securities Group opened 65 new positions and closed 63 in Q2 2024.
  • Daiwa Securities Group's portfolio value rose 6.1% quarter-over-quarter to $18.8B.

Based on Daiwa Securities Group's 13F filing for Q2 2024, filed 7 Aug 2024.